RenovoRx (RNXT) executive discloses direct ownership of 25,000 shares
Rhea-AI Filing Summary
RenovoRx, Inc. filed an initial ownership report for company executive Mark Voll. The filing shows he directly holds 25,000 shares of RenovoRx common stock. A footnote explains these securities were purchased in open-market transactions before his appointment to a senior executive role at the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
VOLL MARK
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 25,000 shares (Direct)
Footnotes (1)
- [object Object]
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Mark Voll's Form 3 filing for RNXT report?
The Form 3 for RenovoRx (RNXT) reports that executive Mark Voll directly holds 25,000 shares of common stock. This is an initial ownership statement, not a new trade, establishing his existing equity position as an insider.
Does Mark Voll’s Form 3 for RenovoRx indicate any insider buying or selling?
The Form 3 does not show a new insider trade. It classifies the entry as a holding, simply reporting that Mark Voll directly owns 25,000 common shares, which were acquired earlier in open-market purchases.
Is Mark Voll’s ownership in RNXT direct or through another entity?
The filing states that Mark Voll’s 25,000 RenovoRx shares are held with direct ownership. There is no indication in the data provided that these shares are held through a trust, partnership, or other indirect entity.